Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-11-20
1989-02-28
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514397, 548336, 548342, 548343, A61K 31415, C07D23364
Patent
active
048086070
ABSTRACT:
Compounds of the formula ##STR1## and the pharmaceutically acceptable acid addition salts thereof, wherein the various substituents are defined hereinbelow and the use thereof for inhibiting cholesterol biosynthesis and lowering the blood cholesterol level and, therefore, in the treatment of hyperlipoproteinemia and atherosclerosis, pharmaceutical compositions comprising such compounds and processes for and intermediates in the synthesis of such compounds.
REFERENCES:
patent: 4530922 (1985-07-01), Moberg
Kassenoff Melvyn M.
Sandoz Pharm. Corp.
Schwartz Richard A.
Sharkin Gerald D.
Vila Richard E.
LandOfFree
Imidazole analogs of mevalonolactone and derivatives thereof for does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazole analogs of mevalonolactone and derivatives thereof for, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole analogs of mevalonolactone and derivatives thereof for will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1367396